State Street
PLRX icon

State Street’s Pliant Therapeutics PLRX Stock Holding History

State Street’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$319K Hold
253,418
– – ﹤0.01% 3762
2025
Q4 		$309K Sell
253,418
-416
-0.2% -$625 ﹤0.01% 3801
2025
Q3 		$376K Hold
253,834
– – ﹤0.01% 3726
2025
Q2 		$294K Sell
253,834
-1,025,860
-80% -$1.45M ﹤0.01% 3732
2025
Q1 		$1.73M Sell
1,279,694
-105,542
-8% -$641K ﹤0.01% 3296
2024
Q4 		$18.2M Sell
1,385,236
-17,494
-1% -$239K ﹤0.01% 2277
2024
Q3 		$15.7M Buy
1,402,730
+26,610
+2% +$333K ﹤0.01% 2352
2024
Q2 		$14.8M Buy
1,376,120
+57,353
+4% +$739K ﹤0.01% 2323
2024
Q1 		$19.6M Sell
1,318,767
-16,511
-1% -$272K ﹤0.01% 2205
2023
Q4 		$24.2M Buy
1,335,278
+17,477
+1% +$266K ﹤0.01% 2108
2023
Q3 		$22.9M Buy
1,317,801
+112,861
+9% +$1.96M ﹤0.01% 2091
2023
Q2 		$21.8M Buy
1,204,940
+914,839
+315% +$21.7M ﹤0.01% 2199
2023
Q1 		$7.72M Buy
290,101
+29,276
+11% +$833K ﹤0.01% 2801
2022
Q4 		$5.04M Buy
260,825
+47,244
+22% +$988K ﹤0.01% 3042
2022
Q3 		$4.46M Buy
213,581
+128,113
+150% +$2.45M ﹤0.01% 3116
2022
Q2 		$685K Sell
85,468
-361,528
-81% -$2.31M ﹤0.01% 3722
2022
Q1 		$3.13M Buy
446,996
+2,367
+0.5% +$24.2K ﹤0.01% 3397
2021
Q4 		$6M Buy
444,629
+26,626
+6% +$423K ﹤0.01% 3150
2021
Q3 		$7.06M Buy
418,003
+32,995
+9% +$700K ﹤0.01% 3060
2021
Q2 		$11.2M Buy
385,008
+4,759
+1% +$148K ﹤0.01% 2855
2021
Q1 		$15M Buy
380,249
+199,258
+110% +$6.47M ﹤0.01% 2535
2020
Q4 		$4.11M Buy
180,991
+60,784
+51% +$1.52M ﹤0.01% 3056
2020
Q3 		$2.72M Buy
+120,207
New +$3M ﹤0.01% 3073

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

State Street's PLRX Position: Q1 2026 in Review

State Street held its Pliant Therapeutics (PLRX) position steady in Q1 2026 at 253,418 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

State Street first reported a position in PLRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $24.2M in Q4 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • State Street held 253,418 shares of Pliant Therapeutics worth $319K as of Q1 2026.
  • State Street left its Pliant Therapeutics share count unchanged in Q1 2026.
  • Pliant Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3762 holding.
  • State Street first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • State Street's Pliant Therapeutics position peaked at $24.2M in Q4 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.